Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2002Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial FracturesCsimma, C.; Genant, H.; Valentin-Opran, A.; Amit, Y.; Arbel, R.; Aro, H.; Atar, D.; Bishay, M.; Borner, M.; Chiron, P.; Choong, P.; Cinats, J.; Courtenay, B.; Feibel, R.; Geulette, B.; Gravel, C.; Haas, N.; Raschke, M.; Hammacher, E.; van der Velde, D.; et al.
2008Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemiale Coutre, P.; Ottmann, O.; Giles, F.; Kim, D.; Cortes, J.; Gattermann, N.; Apperley, J.; Larson, R.; Abruzzese, E.; O'Brien, S.; Kuliczkowski, K.; Hochhaus, A.; Mahon, F.; Saglio, G.; Gobbi, M.; Kwong, Y.; Baccarani, M.; Hughes, T.; Martinelli, G.; Radich, J.; et al.
2008SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndromeGilfillan, G.; Selmer, K.; Roxrud, I.; Smith, R.; Kyllerman, M.; Eiklid, K.; Kroken, M.; Mattingsdal, M.; Egeland, T.; Stenmark, H.; Sjoholm, H.; Server, A.; Samuelsson, L.; Christianson, A.; Tarpey, P.; Whibley, A.; Stratton, M.; Futreal, P.; Teague, J.; Edkins, S.; et al.
2008Comparison of twin and autologous transplants for multiple myelomaBashey, A.; Perez, W.; Zhang, M.; Anderson, K.; Ballen, K.; Berenson, J.; To, L.; Fonseca, R.; Freytes, C.; Gale, R.; Gibson, J.; Giralt, S.; Kyle, R.; Lazarus, H.; Maharaj, D.; McCarthy, P.; Milone, G.; Nimer, S.; Pavlovsky, S.; Reece, D.; et al.
2008Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver functionLarson-Meyer, D.; Newcomer, B.; Heilbronn, L.; Volaufova, J.; Smith, S.; Alfonso, A.; Lefevre, M.; Rood, J.; Williamson, D.; Ravussin, E.; DeLany, J.; de Jonge, L.; Nguyen, T.; Martin, C.; Most, M.; Greenway, F.; York-Crowe, E.; Anton, S.; Champagne, C.; Dahmer, B.; et al.
2007An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in Exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlationUpadyaya, M.; Huson, S.; Davies, M.; Thomas, N.; Chuzhanova, N.; Giovannini, S.; Evans, D.; Howard, E.; Kerr, B.; Kerr, B.; Consoli, C.; Side, L.; Adams, D.; Pierpont, M.; Hatchen, R.; Barnicoat, A.; Li, H.; Wallace, P.; Van Biervliet, J.; Stevenson, D.; et al.
2007Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factorAli, A.; Christie, P.; Grigorieva, I.; Harding, B.; Van Esch, H.; Ahmed, S.; Bitner-Glindzicz, M.; Blind, E.; Bloch, C.; Christin, P.; Clayton, P.; Gecz, J.; Gilbert-Dussardier, B.; Guillen-Navarro, E.; Hackett, A.; Halac, I.; Hendy, G.; Lalloo, F.; Mache, C.; Mughal, Z.; et al.
2003Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemiaO'Brien, S.; Guilhot, F.; Larson, R.; Gathmann, I.; Baccarani, M.; Cervantes, F.; Cornelissen, J.; Fischer, T.; Hochhaus, A.; Hughes, T.; Lechner, K.; Nielsen, J.; Rousselot, P.; Reiffers, J.; Saglio, G.; Shepherd, J.; Simonsson, B.; Gratwohl, A.; Goldman, J.; Kantarjian, H.; et al.
2008Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genesKisand, K.; Link, M.; Wolff, A.; Meager, A.; Tserel, L.; Org, T.; Murumagi, A.; Uibo, R.; Willcox, N.; Podkrajek, K.; Battelino, T.; Lobell, A.; Kampe, O.; Lima, K.; Meloni, A.; Ergun-Longmire, B.; Maclaren, N.; Perheentupa, J.; Krohn, K.; Scott, H.; et al.